CureVac N.V.

CVACNASDAQHealthcare

$4.66

+$0.00(+0.00%)

Market Cap$1.0B

P/E Ratio—

52W High$5.72

52W Low$2.475

Avg Volume1.2M

Open$4.57

Beta1.84

Free Cash Flow Financials Revenue

CureVac N.V. (CVAC) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CVAC · free cash flow · updated Jun 8, 2026

Core FCF metrics

CVAC · FCF · TTM · margin & CAGR

Free cash flow was $83.4M for FY2024 (fiscal year ending 2024-12-31), up 125.8% year-over-year The FCF margin was 15.6%.

FY2024 Free Cash Flow$83.4M▲ +125.8% YoY

Trailing 12M (TTM)−$125.1MTrailing 4Q sum · TTM negative vs latest FY positive

FCF Margin15.6%$83.4M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CVAC · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2024Latest$101.9M(18M)$83.4M▲ +125.8%15.6%

FY2023−$267.9M(55M)−$323.1M▲ +14.8%-601.0%

FY2022−$286.2M(93M)−$379.4M▲ +55.9%-562.7%

FY2021−$733.1M(128M)−$861.0M▼ 281.2%-836.0%

FY2020$522.4M(47M)$475.1M▲ +578.9%971.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CVAC · P/FCF · FCF yield · FCF per share

CureVac N.V. (CVAC) valuation ratios are currently unavailable — market cap, share count, or TTM data could not be retrieved from our data provider.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

Valuation ratios are unavailable — market cap, share count, or TTM data could not be retrieved. Individual metrics are shown where available.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2024 · 2024-12-31

Cash flow statement summary

CVAC · cash flow statement · operating / investing / financing

For FY2024, CureVac N.V. generated $101.9M in operating cash flow and spent 18M in capital expenditures, yielding $83.4M in free cash flow.

Operating Activities

+$101.9M

Cash from core business operations

2024-12-31

Investing Activities

−$18.4M

CapEx, acquisitions & investments

2024-12-31

Financing Activities

−$5.1M

Buybacks, dividends & debt

2024-12-31

FCF FormulaOperating CF ($101.9M) − |CapEx| (18M) = FCF ($83.4M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CVAC vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

CureVac N.V.YOU

CVAC

$83.4M+125.8%15.6%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

CureVac N.V. (CVAC) reported free cash flow of $83.4M for FY2024 (fiscal year ending 2024-12-31), up 125.8% year-over-year. The FCF margin was 15.6%.

Based on available data, CureVac N.V. has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $475.1M in FY2020.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CVAC free cash flow · 8 questions

CureVac N.V. free cash flow was $83.4M for FY2024, up 125.8% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$125.1M.

CVAC free cash flowCVAC FCFCVAC FCF 2024CVAC free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · CureVac N.V. · CureVac N.V. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026